Randy Hofmann, PhD, is a Principal Scientist and Group Leader at Excet, Incorporated, with over 10 years of experience in biomedical research within the pharmaceutical and biotech sectors, as well as the Federal government. Randy has a proven track record in molecular and cellular biology, functional genomics, and analytical biochemistry, contributing significantly to the characterization of antibodies and recombinant proteins. Previous roles include project leadership at Garnet BioTherapeutics, GlaxoSmithKline, and the Edgewood Chemical Biological Center, where Randy managed multiple pivotal studies and projects. Randy holds a PhD in Cancer Biology from the University of Maryland School of Medicine and continues pursuing education in Project Management at the University of Delaware.
Location
Wilmington, United States
This person is not in the org chart
This person is not in any offices